Concepedia

Shawn P. Fessler

SP

Statistics

Publications

11

Citations

481

H-Index

10

Active since

1998

Affiliations

Forma Therapeutics (United States)(Current)

Columbia University

Minerva Biotechnologies (United States)

Albert Einstein College of Medicine

Mersana Therapeutics (United States)

Shawn P. Fessler is an author at Forma Therapeutics (United States) specializing in molecular biology, life sciences, and oncology.

ORCID

Publications per year

1998–2023

11

Publications

11

MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells

Shawn P. Fessler, Mark T. Wotkowicz, S. Mahanta et al. · Breast Cancer Research and Treatment · 2009 · 95 citations

, , +12

A Minimal Fragment of MUC1 Mediates Growth of Cancer Cells

S. Mahanta, Shawn P. Fessler, Jae-Hong Park et al. · PLoS ONE · 2008 · 75 citations · Full text

, , +14

Involvement of caspase-cleaved and intact adaptor protein 1 complex in endosomal remodeling in maturing dendritic cells

Laura Santambrogio, Ilaria Potolicchio, Shawn P. Fessler et al. · Nature Immunology · 2005 · 72 citations

, , +15

Control of Adenovirus Early Gene Expression during the Late Phase of Infection

Shawn P. Fessler, C. S. H. Young · Journal of Virology · 1998 · 51 citations · Full text

, , +17

The deubiquitylase USP9X controls ribosomal stalling

Anne Clancy, Claire Heride, Adán Pinto-Fernández et al. · The Journal of Cell Biology · 2020 · 44 citations · Full text

, , +17

1–5 of 11